Catalyst Wire Dossier Catalyst Wire Dossier

ANA773

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANA773, covering 2012-11-14 to 2012-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) [Phase 1]

See pricing